207919-06-0 Usage
Uses
Used in Organic Synthesis:
4-FLUORO-2-(TRIFLUOROMETHYL)BENZAMIDE is used as a key intermediate in organic synthesis for the production of various pharmaceuticals and chemical compounds. Its unique structure allows for the creation of a wide range of derivatives with diverse applications.
Used in Pharmaceutical Research:
In Pharmaceutical Research, 4-FLUORO-2-(TRIFLUOROMETHYL)BENZAMIDE is used as a starting material for the development of new drugs. Its potential biological activities, such as effects on the central nervous system and anti-inflammatory properties, make it a promising candidate for therapeutic applications.
Used in Industrial Applications:
4-FLUORO-2-(TRIFLUOROMETHYL)BENZAMIDE is used in various industrial applications due to its high thermal stability and resistance to chemical reactions. This makes it suitable for use in environments where stability and durability are required.
Used in Central Nervous System Research:
In the field of neuroscience, 4-FLUORO-2-(TRIFLUOROMETHYL)BENZAMIDE is used as a research tool to study its effects on the central nervous system. Understanding its interactions with neurological pathways can lead to the development of treatments for related disorders.
Used in Anti-Inflammatory Research:
4-FLUORO-2-(TRIFLUOROMETHYL)BENZAMIDE is also used in anti-inflammatory research to explore its potential as an anti-inflammatory agent. Its ability to modulate inflammatory responses could contribute to the development of new therapies for inflammatory diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 207919-06-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,9,1 and 9 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 207919-06:
(8*2)+(7*0)+(6*7)+(5*9)+(4*1)+(3*9)+(2*0)+(1*6)=140
140 % 10 = 0
So 207919-06-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H5F4NO/c9-4-1-2-5(7(13)14)6(3-4)8(10,11)12/h1-3H,(H2,13,14)
207919-06-0Relevant articles and documents
Heterocyclic Compounds and Methods of Use
-
Paragraph 0461, (2018/03/01)
This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (NASH); elevated cholesterol levels, and insulin resistance.
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0175, (2015/03/16)
This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists. Compounds of the invention may also find use in treating cancer. Presented herein are novel compounds bearing a perhaloalkylsulfonamide moiety. Such compounds, in addition to being highly effective SREBP inhibitors, are also unexpectedly highly bioavailable in vivo. Heteroaromatic compounds bearing sulfonamide groups are prone to several ionic states, based on the inherent pKa values.
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 0437, (2015/03/16)
This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists.
